PATENT CLAIM ANALYSIS

Application Number: 15752118
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "012900"]

Abstract:
The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin β4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin β4 is carried out in the presence of an inert gas, thus the contact of thymosin β4 with oxygen is blocked and the oxidation of thymosin β4 can be prevented and the pharmacological activity of thymosin β4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin β4 in a stable state for a long time.

Claim (Index 10):
The method of  claim 1 , further comprising the step of providing the sealed container containing the composition into a pouch in the presence of an inert gas.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.92308
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14844421', '11284430', '15520915', '11995817', '13258687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7212485311278264
- 35 USC 102 Novelty (BERT): 0.5277406120260671
- Combined Prediction Score: 0.7018977392176505
- Mean Citation Score: 176.334734
- Max Citation Score: 217.87102
- Similarity Product: 90.95858375285864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test